44.20
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt NVO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Novo Nordisk Adr Aktie (NVO) Neueste Nachrichten
Prediction: These 2 Obesity Drug Stocks Could Double in 2026 - The Motley Fool
Caution with BioNTech! Novo Nordisk Accelerates! Buying Opportunity in Vidac Pharma Stock? - news.financial
Novo Nordisk Turns To OpenAI To Tighten Drug Development And Supply Chain - Sahm
NVO Stock Chart | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
NVO Stock Price, Quote & Chart | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
NVO Stock Quote Price and Forecast - CNN
Novo Nordisk A/S ADR (NVO-N) Stock Price and News - The Globe and Mail
Novo Nordisk stock (DK0062498333): Wegovy growth and U.S. demand stay in focus - AD HOC NEWS
Novo Nordisk A/ S stock (DK0060534915): weight-loss boom meets fresh earnings update - AD HOC NEWS
NVO Technical Analysis | Trend, Signals & Chart Patterns | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
Novo Nordisk A/S stock (DK0062498333): weight-loss demand drives fresh guidance upgrade - AD HOC NEWS
Novo Nordisk A/S stock (DK0062498333): Wegovy data and earnings outlook keep GLP-1 race in focus - AD HOC NEWS
Novo Nordisk Highlights New Wegovy Pill Data - Sahm
Novo Nordisk A/ S stock (DK0060534915): Up 1.29% to $47 amid recovery trend - AD HOC NEWS
ETFs Investing in Novo Nordisk A/S Sponsored ADR Class B Stocks - TradingView
Novo Nordisk A/ S stock (DK0062498333): Wegovy data fuels 3% premarket surge - AD HOC NEWS
Novo Nordisk Presents New Wegovy Data Showing Strong Weight Loss, Fat Reduction - Sahm
Amazon Pharmacy Deal Puts Novo Nordisk Access And Valuation In Focus - Sahm
Novo Nordisk A/S stock (DK0060534915): Weight-loss and diabetes leader faces new pricing pressures - AD HOC NEWS
Novo Nordisk A/S stock (DK0062498333): Q1 beats and 2026 outlook lift shares on Nasdaq Copenhagen an - AD HOC NEWS
Wegovy Pill Debut 'Fattens' Novo Nordisk's Profit Outlook - Sahm
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 15 Years - Sahm
Market news - investments.halifax.co.uk
Shares in Novo Nordisk jump after Wegovy pill sales smash forecasts - Sharecast.com
Novo Nordisk Earnings: Impressive Wegovy Pill Sales and Encouraging International Launch Timeline - Morningstar
FDA Proposal Could Support Novo Nordisk GLP‑1 Exclusivity And Valuation - Sahm
European ADRs Jumped In US Trading, Led By Novo Nordisk - Finimize
Novo Nordisk’s Oral Ozempic And Pediatric Plans Reframe GLP-1 Opportunity - Sahm
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):